Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 96451-96500 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT04580732
"Clinical Trial of the MiniStim PNS for Knee Pain- FLEX Study"
NARecruiting
350 participants
Started: May 5, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT04918732
NAFLD Primary Care
NARecruiting
1,470 participants
Started: May 5, 2021 · Completed: Dec 31, 2024
5 conditions1 sponsor1 location
NCT04777331
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease
PHASE2Active, not recruiting
586 participants
Started: May 5, 2021 · Completed: Dec 30, 2026
1 condition2 sponsors110 locations
NCT04847284
Intraoperative Radiotherapy in Patients With Brain Metastases
NARecruiting
25 participants
Started: May 5, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04691544
Donor Versus Autologous Fecal Microbiota Transplantation for Irritable Bowel Syndrome
PHASE3Active, not recruiting
450 participants
Started: May 5, 2021 · Completed: Dec 31, 2026
1 condition5 sponsors1 location
NCT04878991
Overture Metabolomics Non-Selection Study
N/ARecruiting
410 participants
Started: May 5, 2021 · Completed: Jan 30, 2024
1 condition3 sponsors2 locations
NCT05592314
Lnfluence of the Prosthetic Emergence Profile on the Prevalence of Peri-implant Diseases
N/ARecruiting
120 participants
Started: May 5, 2021 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT04652570
Efficacy and Safety of VB119 in Subjects With Membranous Nephropathy
PHASE1/PHASE2Active, not recruiting
6 participants
Started: May 5, 2021 · Completed: Aug 15, 2024
1 condition1 sponsor4 locations
NCT04593888
Gluten Reduction and Risk of Celiac Disease
NAActive, not recruiting
1,141 participants
Started: May 5, 2021 · Completed: Dec 31, 2035
3 conditions1 sponsor1 location
NCT04800588
Computerized Tests of Cognitive Decline in Presymptomatic Alzheimer's Disease
NARecruiting
2,000 participants
Started: May 5, 2021 · Completed: Mar 31, 2027
3 conditions2 sponsors1 location
NCT04605146
Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy
NARecruiting
100 participants
Started: May 5, 2021 · Completed: Nov 5, 2028
3 conditions1 sponsor10 locations
NCT04769362
Long-term Beta-blocker Therapy After Acute Myocardial Infarction
PHASE4Recruiting
2,540 participants
Started: May 4, 2021 · Completed: Mar 31, 2026
1 condition21 sponsors1 location
NCT06227611
Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients with Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.
N/ARecruiting
16 participants
Started: May 4, 2021 · Completed: May 4, 2025
1 condition1 sponsor2 locations
NCT04809740
Evaluating the Implementation and Impact of Navigator-delivered ePRO System
NARecruiting
7,500 participants
Started: May 4, 2021 · Completed: Jan 31, 2027
1 condition2 sponsors2 locations
NCT04801953
Nimodipine in Vestibular Schwanommas
PHASE2Recruiting
30 participants
Started: May 4, 2021 · Completed: Apr 9, 2024
1 condition1 sponsor1 location
NCT04873362
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
PHASE3Active, not recruiting
1,188 participants
Started: May 4, 2021 · Completed: Oct 2, 2034
1 condition1 sponsor239 locations
NCT04734756
Safety and Effectiveness Study of Dragonfly System for Degenerative Mitral Regurgitation
NAEnrolling by invitation
120 participants
Started: May 4, 2021 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT04372953
Positive End-Expiratory Pressure (PEEP) Levels During Resuscitation of Preterm Infants at Birth (The POLAR Trial).
NARecruiting
906 participants
Started: May 4, 2021 · Completed: May 30, 2028
2 conditions4 sponsors28 locations
NCT05211518
Prevention of Inflammatory Bowel Diseases in Persons at Risk The PIONIR (Preventing IBD Onset in Individuals at Risk) Trial
NAActive, not recruiting
30 participants
Started: May 4, 2021 · Completed: Dec 1, 2025
1 condition10 sponsors1 location
NCT04880590
Sex or no Sex: That is the Question.
N/ARecruiting
2,500 participants
Started: May 4, 2021 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT04853576
A Study Evaluating the Safety and Efficacy of EDIT-301 in Participants With Severe Sickle Cell Disease (RUBY)
PHASE1/PHASE2Active, not recruiting
45 participants
Started: May 4, 2021 · Completed: Aug 31, 2025
2 conditions1 sponsor24 locations
NCT04779827
Improving Health Equity for COVID-19 Vaccination for At-risk Populations Using Online Social Networks
NAActive, not recruiting
4,476 participants
Started: May 4, 2021 · Completed: Jan 30, 2026
3 conditions4 sponsors1 location
NCT04818502
Real World Study of the Tendyne™ Mitral Valve System to Treat Mitral Regurgitation
N/AActive, not recruiting
200 participants
Started: May 4, 2021 · Completed: May 31, 2029
1 condition1 sponsor36 locations
NCT06322277
Use of Low-cost Molecular Diagnostic Techniques as a New Surveillance Model for Diseases Preventable by Vaccinations.
NARecruiting
1 participants
Started: May 4, 2021 · Completed: Mar 31, 2025
1 condition1 sponsor4 locations
NCT04734730
Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate Cancer
PHASE2Recruiting
70 participants
Started: May 4, 2021 · Completed: Aug 23, 2027
5 conditions2 sponsors1 location
NCT04742673
Maximizing trEatment of Neurological Dysfunction Using INtravenous Guanfacine Study
PHASE2Active, not recruiting
46 participants
Started: May 4, 2021 · Completed: Dec 31, 2025
3 conditions3 sponsors1 location
NCT03527537
Gestational Diabetes and Pharmacotherapy (GAP)
PHASE4Recruiting
416 participants
Started: May 4, 2021 · Completed: Oct 1, 2026
1 condition2 sponsors1 location
NCT04232358
Resistance Training and Injection Treatment for Achilles Enthesopathy
NAActive, not recruiting
50 participants
Started: May 4, 2021 · Completed: May 4, 2025
1 condition1 sponsor1 location
NCT04475731
Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse
PHASE2Active, not recruiting
67 participants
Started: May 4, 2021 · Completed: Nov 30, 2024
2 conditions1 sponsor22 locations
NCT04416451
A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma
PHASE2Active, not recruiting
6 participants
Started: May 4, 2021 · Completed: Jun 30, 2026
1 condition2 sponsors8 locations
NCT04737460
Study for the Treatment for CLN7 Disease
PHASE1Active, not recruiting
4 participants
Started: May 4, 2021 · Completed: Feb 1, 2029
1 condition1 sponsor1 location
NCT04688593
Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up
N/ARecruiting
520 participants
Started: May 4, 2021 · Completed: Jan 31, 2036
4 conditions1 sponsor2 locations
NCT05228509
Portal Vein Flow Velocity as a Screening Tool for Oesophageal Varices in Cirrhotic Patients
N/ARecruiting
75 participants
Started: May 4, 2021 · Completed: Dec 30, 2024
1 condition1 sponsor2 locations
NCT04588285
Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial
PHASE2Recruiting
180 participants
Started: May 4, 2021 · Completed: Jul 1, 2025
1 condition3 sponsors1 location
NCT04922606
Great Saphenous Vein Anatomy at the Proximal Medial Thigh as a Potential Site for Rescue Venous Access
NAEnrolling by invitation
190 participants
Started: May 4, 2021 · Completed: May 31, 2045
1 condition1 sponsor1 location
NCT04269590
Triggering Motor Memory Consolidation in PD: Complex Practice of Fine Motor Tasks and Brain Activity During Learning
NAActive, not recruiting
80 participants
Started: May 3, 2021 · Completed: Mar 31, 2024
1 condition1 sponsor1 location
NCT04595747
Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)
PHASE2Active, not recruiting
48 participants
Started: May 3, 2021 · Completed: Jul 1, 2026
8 conditions1 sponsor18 locations
NCT05511298
Empowering Students Project
N/ARecruiting
1,332 participants
Started: May 3, 2021 · Completed: Sep 29, 2025
1 condition1 sponsor1 location
NCT04876222
Direct or Subacute Coronary Angiography in Patients With Out of Hospital Cardiac Arrest Without Coma.
NARecruiting
1,200 participants
Started: May 3, 2021 · Completed: May 1, 2027
4 conditions4 sponsors7 locations
NCT03876262
Safety and Efficacy of Annual or Biannual Doses of Moxidectin or Ivermectin for Onchocerciasis
PHASE3Active, not recruiting
323 participants
Started: May 3, 2021 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT04910802
Concomitant HPV Vaccination and HPV Screening HPV Infection and Cervical Cancer in Sweden
PHASE4Recruiting
150,000 participants
Started: May 3, 2021 · Completed: Dec 31, 2027
3 conditions2 sponsors1 location
NCT04787471
Corneal Crosslinking for Treatment of Corneal Neovascularization
PHASE2/PHASE3Recruiting
62 participants
Started: May 3, 2021 · Completed: Sep 15, 2026
1 condition2 sponsors1 location
NCT04660344
A Study of Atezolizumab Versus Placebo as Adjuvant Therapy in Patients With High-Risk Muscle-Invasive Bladder Cancer Who Are ctDNA Positive Following Cystectomy
PHASE3Active, not recruiting
761 participants
Started: May 3, 2021 · Completed: Sep 13, 2026
1 condition2 sponsors161 locations
NCT05740397
Trial to Compare Different Strategies of Mean Arterial Pressure Management During Cardiopulmonary By-pass
NARecruiting
900 participants
Started: May 3, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT04774445
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
NAActive, not recruiting
400 participants
Started: May 3, 2021 · Completed: Apr 1, 2026
2 conditions2 sponsors1 location
NCT04700072
Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)
PHASE1/PHASE2Active, not recruiting
300 participants
Started: May 3, 2021 · Completed: Apr 3, 2030
1 condition1 sponsor36 locations
NCT05987579
Surgical Treatment of Stage T3 Squamous Cell Carcinomas of the Scalp
N/AActive, not recruiting
104 participants
Started: May 3, 2021 · Completed: Dec 1, 2025
3 conditions1 sponsor1 location
NCT04880733
Acupuncture in the Emergency Department for Pain Management
NAActive, not recruiting
290 participants
Started: May 3, 2021 · Completed: Aug 31, 2025
4 conditions5 sponsors4 locations
NCT04926207
The Effects of Interrupting Prolonged Sitting With Bouts of Physical Activity on Neurocognitive Function in Obesity
NAActive, not recruiting
45 participants
Started: May 3, 2021 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT04902872
Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors
PHASE1/PHASE2Active, not recruiting
130 participants
Started: May 3, 2021 · Completed: Jun 30, 2025
12 conditions1 sponsor4 locations